ניטרודרם 5 TTS ישראל - עברית - Ministry of Health

ניטרודרם 5 tts

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ניטרודרם 5 TTS ישראל - עברית - Ministry of Health

ניטרודרם 5 tts

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ניטרודרם 10 TTS ישראל - עברית - Ministry of Health

ניטרודרם 10 tts

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ניטרודרם 10 TTS ישראל - עברית - Ministry of Health

ניטרודרם 10 tts

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

אקספורג' 5 מ"ג/ 320 מ"ג ישראל - עברית - Ministry of Health

אקספורג' 5 מ"ג/ 320 מ"ג

novartis pharma services ag - amlodipine as besylate 5 mg; valsartan 320 mg - film coated tablets - valsartan - exforge ( amlodipine and valsartan) is insicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension.

אקספורג' 10 מ"ג/ 320 מ"ג ישראל - עברית - Ministry of Health

אקספורג' 10 מ"ג/ 320 מ"ג

novartis pharma services ag - amlodipine as besylate 10 mg; valsartan 320 mg - film coated tablets - valsartan - exforge ( amlodipine and valsartan) is insicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension.

סביבו ישראל - עברית - Ministry of Health

סביבו

novartis pharma services ag - telbivudine 600 mg - film coated tablets - telbivudine - treatment of chronic hepatitis b in patients with evidence of viral replication and active liver inflammation in adults over 16 years of age.the following points should be considered when initiating therapy with sebivo:- for hbeag - positive patients, sebivo treatment should only be initiated in patients with baseline hbv dna < 9log 10 copies/ml and baseline alt>or= 2x uln.- for hbeag - negative patients, sebivo treatment should only be initiated in patients with baseline hbv dna < 7log 10 copies/ml.

ויזודיין ישראל - עברית - Ministry of Health

ויזודיין

novartis pharma services ag - verteporfin 15 mg/vial - solution for infusion - verteporfin - visudyne is indicated for the treatment of patients with predominantly classic or occult subfoveal choroidal neovascularization due to age related macular degeneration, or with subfoveal choroidal neovascularization caused by other macular diseases.

גליבק 100 מ"ג כמוסות ישראל - עברית - Ministry of Health

גליבק 100 מ"ג כמוסות

novartis pharma services ag - imatinib as mesylate 100 mg - capsules - imatinib - treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ - cml) in chronic phase, accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist).

גליבק ® 100 מ"ג ישראל - עברית - Ministry of Health

גליבק ® 100 מ"ג

novartis pharma services ag - imatinib as mesylate 100 mg - film coated tablets - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l